📋 Tender Overview
Supply of a biosynthetic insulin product consisting of a mixture of 50% soluble insulin aspart and 50% protamine crystallized insulin, packaged in 3 ml cartridges with a complimentary pen and ultrafine nano needle. Inj. Biosynthetic r-DNA Origin mixture of 50% soluble insulin aspart and 50% protamine crystallized insulin Aspart 100IU/ml 03 ml Cartridge with Complimentary Pen and ultrafine nano needle
